Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human S1PR2 Stable Cell Line

    [CAT#: S01YF-0923-PY105]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    S1PR2
    Target Family
    Lysophospholipid Family
    Target Protein Species
    Mouse
    Host Cell Type
    bEnd.3;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    CNS Research;Cardiovascular Research
    Related Diseases
    Deafness, Autosomal Recessive 68;Rare Autosomal Recessive Non-Syndromic Sensorineural Deafness Type Dfnb
    Gene ID
    Mouse: 14739
    UniProt ID
    Mouse: P52592

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    S1PR2 has garnered attention for its involvement in various cellular processes, including cell proliferation, migration, and angiogenesis. Recent studies have highlighted its role in renal carcinoma, where it influences the proliferation and migration of cancer cells through pathways like the S1PR2/FAK. Additionally, its association with neuroinflammation and neurotransmission alterations in conditions like hyperammonaemia has been explored. The receptor's involvement in vascular endothelial barrier function and its potential as a therapeutic target for inflammatory bowel disease further underscores its significance in health and disease.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human S1PR2 Stable Cell Line (S01YF-0923-PY105). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Timothy (Verified Customer)

    How does S1PR2 influence resistance to 5-FU in colorectal cancer? Jun 18 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    S1PR2 inhibitors, such as JTE-013, have demonstrated the ability to reverse 5-FU resistance in colorectal cancer. This is achieved by blocking S1PR2 internalization to the endoplasmic reticulum (ER), which in turn inhibits the degradation of 5-FU into α-fluoro-β-alanine (FBAL) by downregulating tumoral DPD expression. Jun 18 2021

    chat Kimberly (Verified Customer)

    What role does S1PR2 play in cell migration and invasion in multiple myeloma? Dec 25 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    The downregulation of S1PR2 may contribute to the initial extramedullary translocation in multiple myeloma by promoting cell migration and invasion. This process is facilitated through the activation of the NF-κB pathway. Dec 25 2022

    Published Data

    Fig.1 Silencing S1PR2 hampers cPLA2 phosphorylation, a process potentiated by H2O2, through the reduction of p38 and Erk1/2 activation in bEnd3 cells.

    Immunoblotting was performed on lysates from lentivirus-infected bEnd3 cells subjected to a 30-minute exposure of 2 mM H2O2, using specified antibodies for analysis.

    Ref: Cao, Changchun, et al. "S1PR2 antagonist alleviates oxidative stress-enhanced brain endothelial permeability by attenuating p38 and Erk1/2-dependent cPLA2 phosphorylation." Cellular Signalling 53 (2019): 151-161.

    Pubmed: 30290210

    DOI: 10.1016/j.cellsig.2018.09.019

    Research Highlights

    Skoug C, et al. "Density of Sphingosine-1-Phosphate Receptors Is Altered in Cortical ." Neurochemical research, 2023.
    The present study aimed to investigate the potential alterations in sphingosine-1-phosphate (S1P) signaling in nerve terminals of insulin-resistant and diet-induced obese animal models of type 2 diabetes (T2D). S1P is a phosphosphingolipid with diverse biological functions and has been reported to play a role in neurodegenerative disorders. Our previous research has shown that neurons possess S1P receptors (S1PRs) with distinct localization and neuromodulatory effects. The current study used synaptosomes from the cortex of Goto-Kakizaki (GK) rats and Wistar controls, as well as mice fed a high-fat diet (HFD) and low-fat controls, to determine the density of S1PRs. Results showed lower levels of S1PR1, S1PR2, and S1PR4 in nerve-terminal-enriched membranes of GK rats, despite similar levels of S1P in the cortex compared to controls. On the other hand, HFD-fed mice exhibited increased levels of S1P in both plasma and cortex, along with decreased density of S1PR1 and S1PR4. These findings indicate altered S1P signaling in synapses of insulin resistance and obesity models, suggesting a potential role of S1P in the synaptic dysfunction associated with T2D.
    Pubmed: 37794263   DOI: 10.1007/s11064-023-04033-4

    Kim H, et al. "Clinical Significance of Sphingosine 1-phosphate Receptor 2 and Takeda G ." Journal of gastrointestinal and liver diseases : JGLD, 2023.
    In biliary epithelial cells, two bile acid receptors, S1PR2 and TGR5, have been found to promote cell proliferation and invasive behavior in cancerous cells. The purpose of this study was to determine the clinical relevance of S1PR2 and TGR5 expression in patients with extrahepatic cholangiocarcinoma (CCA). A total of 115 patients who underwent surgical resection at Korea University Guro Hospital from 2002 to 2018 were included. The expression levels of S1PR2 and TGR5 were evaluated using digital image analysis. Results showed a significant decrease in S1PR2 expression (p=0.052) and a significant increase in TGR5 expression (p=0.02) in invasive CCA. Low S1PR2 expression was associated with reduced overall and disease-free survival rates (p<0.05), while TGR5 expression did not show significance (p=0.096). Multivariate analysis revealed low S1PR2 to be the only independent predictor of poor prognosis. Therefore, low S1PR2 expression may indicate a negative outcome in patients with resected extrahepatic CCA.
    Pubmed: 37774230   DOI: 10.15403/jgld-4841

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare